| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
89,554,000 |
| Market
Cap: |
2.19(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$20.02 - $46.03 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Intellia Therapeutics is a genome editing company focused on developing therapeutics using CRISPR/Cas9 technology. CRISPR/Cas9, an acronym for Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated 9 (Cas9), is a technology for genome editing, the process of altering selected sequences of genomic deoxyribonucleic acid (DNA). To realize the transformative potential of CRISPR/Cas9-based technologies, Co. is building a range of genome editing company, by utilizing its modular platform, to advance in vivo and ex vivo therapies for diseases with high unmet need.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
2,902 |
53,430 |
61,187 |
62,275 |
| Total Sell Value |
$95,737 |
$1,583,155 |
$1,913,663 |
$1,961,404 |
| Total People Sold |
2 |
7 |
8 |
8 |
| Total Sell Transactions |
2 |
10 |
15 |
16 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rivera Jose E |
EVP, General Counsel |
• – – |
2020-10-15 |
4 |
OE |
$6.83 |
$68,300 |
D/D |
10,000 |
46,294 |
|
- |
|
| Leonard John M. |
President and CEO |
• • – |
2020-10-07 |
4 |
AS |
$21.83 |
$109,150 |
D/D |
(5,000) |
467,352 |
|
180% |
|
| Leonard John M. |
President and CEO |
• • – |
2020-10-07 |
4 |
OE |
$6.83 |
$34,150 |
D/D |
5,000 |
472,352 |
|
- |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-09-15 |
4 |
AS |
$21.04 |
$118,140 |
D/D |
(5,615) |
36,294 |
|
161% |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-09-15 |
4 |
OE |
$6.83 |
$68,300 |
D/D |
10,000 |
41,909 |
|
- |
|
| Leonard John M. |
President and CEO |
• • – |
2020-09-01 |
4 |
AS |
$21.83 |
$109,150 |
D/D |
(5,000) |
467,352 |
|
258% |
|
| Leonard John M. |
President and CEO |
• • – |
2020-09-01 |
4 |
OE |
$6.83 |
$34,150 |
D/D |
5,000 |
472,352 |
|
- |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-08-18 |
4 |
AS |
$21.00 |
$117,915 |
D/D |
(5,615) |
31,909 |
|
167% |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-08-18 |
4 |
OE |
$6.83 |
$68,300 |
D/D |
10,000 |
37,524 |
|
- |
|
| Leonard John M. |
President and CEO |
• • – |
2020-08-06 |
4 |
AS |
$21.83 |
$109,150 |
D/D |
(5,000) |
467,352 |
|
173% |
|
| Leonard John M. |
President and CEO |
• • – |
2020-08-06 |
4 |
OE |
$6.83 |
$34,150 |
D/D |
5,000 |
472,352 |
|
- |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-07-15 |
4 |
AS |
$22.70 |
$127,461 |
D/D |
(5,615) |
27,524 |
|
54% |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-07-15 |
4 |
OE |
$6.83 |
$68,300 |
D/D |
10,000 |
33,139 |
|
- |
|
| Leonard John M. |
President and CEO |
• • – |
2020-07-01 |
4 |
AS |
$21.83 |
$109,150 |
D/D |
(5,000) |
467,352 |
|
35% |
|
| Leonard John M. |
President and CEO |
• • – |
2020-07-01 |
4 |
OE |
$6.83 |
$34,150 |
D/D |
5,000 |
472,352 |
|
- |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-06-16 |
4 |
AS |
$21.00 |
$117,915 |
D/D |
(5,615) |
22,282 |
|
21% |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-06-16 |
4 |
OE |
$6.83 |
$68,300 |
D/D |
10,000 |
27,897 |
|
- |
|
| Leonard John M. |
President and CEO |
• • – |
2020-06-03 |
4 |
AS |
$21.83 |
$109,150 |
D/D |
(5,000) |
467,352 |
|
11% |
|
| Leonard John M. |
President and CEO |
• • – |
2020-06-03 |
4 |
OE |
$6.83 |
$34,150 |
D/D |
5,000 |
472,352 |
|
- |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-05-26 |
4 |
AS |
$21.21 |
$119,094 |
D/D |
(5,615) |
280,107 |
|
10% |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-05-26 |
4 |
OE |
$6.83 |
$68,300 |
D/D |
10,000 |
285,722 |
|
- |
|
| Schiermeier Andrew |
EVP, Dev and Corp Strategy |
• – – |
2019-03-06 |
4 |
B |
$15.50 |
$117,875 |
D/D |
7,500 |
7,500 |
2.74 |
- |
|
| Cohen Fred E |
Director |
– • – |
2019-03-01 |
4 |
A |
$16.89 |
$168,936 |
D/D |
10,000 |
10,000 |
|
- |
|
| Formela Jean Francois |
Director |
– • – |
2018-07-16 |
4 |
AS |
$30.97 |
$208,397 |
I/I |
(6,686) |
0 |
|
- |
|
| Formela Jean Francois |
Director |
– • – |
2018-06-19 |
4 |
AS |
$27.84 |
$186,908 |
I/I |
(6,686) |
0 |
|
- |
|
245 Records found
|
|
Page 8 of 10 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.40 (1.61%) 
